Methods of use comprising a biocidal polyamine
US-9220267-B2 · Dec 29, 2015 · US
US9439433B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9439433-B2 |
| Application number | US-201414507701-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 6, 2014 |
| Priority date | May 22, 2013 |
| Publication date | Sep 13, 2016 |
| Grant date | Sep 13, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds, compositions, and methods comprising a polyamine compound are described, which may be used to kill, disperse, treat, or reduce biofilms, or to inhibit or substantially prevent biofilm formation. In certain aspects, the present invention relates to compounds, compositions, and methods comprising polyamine compounds that have antimicrobial or dispersing activity against a variety of bacterial strains capable of forming biofilms.
Opening claim text (preview).
What is claimed is: 1. A method for dispersing or killing a biofilm, the method comprising a step of contacting the biofilm with an anti-biofilm composition, thereby dispersing or killing the biofilm; wherein the anti-biofilm composition comprises a polyamine compound selected from the group consisting of and a salt thereof; wherein: each R a is a member independently selected from the group consisting of A 1 , A 2 , A 3 , A 4 and A 5 are each an A n member independently selected from the group consisting of N, CR a , and CR 5 ; or, alternatively, a pair of adjacent A n members join to form an additional, independently selected aryl, cycloalkyl, heterocyclyl, or heterocycloaryl ring; wherein at least one A n member and at most three A n members are each an independently selected CR a ; each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl; each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl; alternatively, a pair of R 2 members from the same R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a member independently selected from the group consisting of spirocycloalkyl, spiroheterocycyl, and oxo; or, alternatively, an R 2a and an R 2c from the same R a group join to form a ring that is independently selected from the group consisting of cycloalkyl and heterocycyl; each R m is a member independently selected from the group consisting of —CR 2a R 2b —, —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L-C(R 2c )(R 2d )—; each m is an integer independently selected from 1 to 16; each L is a member independently selected from the group consisting of a bond, —O—, —C(O)O—, —NR 4 —, —NR 4 C(O)—, and —C(O)NR 4 —; each R 3 is a member independently selected from the group consisting of —Z 1 —R 4 , —Z 1 —Y 1 —R 4 , —Z 1 —Y 1 —Y 2 —R 4 , and —Z 1 —Y 1 —Y 2 —Y 3 —R 4 ; each R 4 is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, cycloalkyl, heteroaryl, arylalkyl, cycloalkylalkyl, and heteroarylalkyl; or, alternatively, for an —N(R 4 ) 2 group, one of the two R 4 in the group is a member selected from the group consisting of —(CO)OR 6a —, —(CO)N(R 6a )(R 6b ), and —C(NR 6a )N(R 6b )(R 6c ); or, alternatively, for an —N(R 4 ) 2 group, the two R 4 groups join to form a heterocyclic ring; each R 5 is a member independently selected from the group consisting of hydrogen, alkyl, hydroxyl, alkoxy, aminoalkoxy, alkylamino, alkylaminoalkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkoxy, cycloalkylalkoxy, cycloalkylamino, cycloalkylalkylamino, heterocyclyl, heterocycyloxy, heterocycylamino, halo, haloalkyl, fluoroalkyloxy, arylalkyl, arylalkyloxy, arylalkylamino, n6m-heteroaryl, n6m-heteroaryloxy, heteroarylalkyl, heteroarylalkyloxy, heteroarylalkylamino, hydroxyalkyl, aminoalkyl, and alkylaminoalkyl; wherein at least one R 5 is not hydrogen; each Y 1 , Y 2 , and Y 3 is an independently selected group of Formula IA: each Z 1 and Z 2 is a member independently selected from the group consisting of —N(R 4 )— and —O—; and each R 6a , R 6b , and R 6c is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, arylalkyl, heteroarylalkyl, and cycloalkylalkyl; or, alternatively, two R 6n members R 6a and R 6b or R 6a and R 6c join to form a heterocycyl ring; wherein the polyamine compound comprises at least two primary or secondary amino groups; and with the proviso that —Z 1 —R 4 and —Z 2 —R 4 are not —NH 2 . 2. The method of claim 1 , wherein the biofilm comprises an antibiotic-resistant bacterial species. 3. The method of claim 1 , wherein the polyamine compound comprises at least four primary or secondary amino groups. 4. The method of claim 1 , wherein the polyamine compound comprises at least six primary or secondary amino groups. 5. The method of claim 1 , wherein the polyamine compound is a hydrochloride salt of 6. The method of claim 3 , wherein the polyamine compound is selected from the group consisting of and a salt thereof; wherein each A n member is an independently selected CR 5 . 7. The method of claim 6 , wherein: each R a is independently a group of Formula II: each of the A n members is independently selected from the group consisting of CR a and CR 5 ; or, alternatively, a pair of adjacent A n members join to form an additional, independently selected cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl; and for each R a member, at most two R m of the R a member are selected from the group consisting of —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L-C(R 2c )(R 2d ). 8. The method of claim 7 , wherein: each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl; alternatively, a pair of R 2n members from the R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a ring independently selected from the group consisting of spirocycloalkyl and spiroheterocycyl; or, alternatively, the R 2a and the R 2c from the R a group join to form a ring independently selected from the group consisting of cycloalkyl and heterocycyl; each m is an integer independently selected from 1 to 12; each R 3 is a member independently selected from the group consisting of —Z 1 —Y 1 —R 4 and —Z 1 —Y 1 —Y 2 —R 4 ; and each Z 1 and Z 2 is an independently selected NR 4 . 9. The method of claim 6 , wherein: A 1 , A 2 , A 3 , A 4 , and A 5 are each an A n member independently selected from the group consisting of CR a , and CR 5 ; or, alternatively, a pair of adjacent A n members join to form an additional cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; each m is an integer independently selected from 1 to 10; each L is a member independently selected from the group consisting of a bond, —O—, and —NR 4 —; each R 3 is a member independently selected from the group consisting of —Z 1 —R 4 , —Z 1 —Y 1 —R 4 , and —Z 1 —Y 1 —Y 2 —R 4 ; and each Z 1 and Z 2 is an independently selected NR 4 . 10. The method of claim 9 , wherein: each R a is independently a group of Formula V:
Laboratory, medical or dentistry appliances, e.g. catheters or sharps · CPC title
Living organisms or biological materials · CPC title
Anti-perspirants or body deodorants (deodorisation of air A61L9/00) · CPC title
Radicals substituted by nitrogen atoms (nitro radicals C07D317/52) · CPC title
Amines · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.